Vanillic acid: A potential inhibitor of cardiac and aortic wall remodeling in l-NAME induced hypertension through upregulation of endothelial nitric oxide synthase

Environmental Toxicology and Pharmacology

Volumn 38, Issue 2, 2014, Pages 643-652

  Kumar, Subramanian ^a   Prahalathan, Pichavaram ^a   Raja, Boobalan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Cardiac marker enzymes; ENOS expression; Hypertension; L NAME; Left ventricular function; Vanillic acid

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; N(G) NITROARGININE METHYL ESTER; VANILLIC ACID; NOS3 PROTEIN, MOUSE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HISTOPATHOLOGY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGAN WEIGHT; PROTEIN EXPRESSION; RAT; ULTRASTRUCTURE; UPREGULATION; WISTAR ALBINO GLAXO RAT; ANIMAL; AORTA; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; WISTAR RAT;

ANIMALS; AORTA; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPERTENSION; MALE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; RATS, WISTAR; VANILLIC ACID; VENTRICULAR FUNCTION, LEFT;

EID: 84908453759     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2014.07.011     Document Type: Article

References (66)

1. Afkir S., Nguelefack T.B., Aziz M., Zoheir J., Cuisinaud G., Bnouham M., Mekhfi H., Legssyer A., Lahlou S., Ziyyat A. Arbutus unedo prevents cardiovascular and morphological alterations in l-NAME-induced hypertensive rats Part I: cardiovascular and renal hemodynamic effects of Arbutus unedo in l-NAME-induced hypertensive rats. J. Ethnopharmacol. 2008, 116:288-295.
2. Akuzawa N., Nakamura T., Kurashina T., Saito Y., Hoshino J., Sakamoto H., Sumino H., Ono Z., Nagai R. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis. Am. J. Hypertens. 1998, 11:697-707.
3. Argolo A.C., Sant'Ana A.E., Pletsch M., Coelho L.C. Antioxidant activity of leaf extracts from Bauhinia monandra. Bioresour. Technol. 2004, 95:229-233.
4. Ayano I., Katsuhiro I., Masuo K., Masaya K., Akihiro W., Masakazu K., Makoto T., Kiyohito Y. Hepatoprotective effect of syringic acid and vanillic acid on CCl4-induced liver injury. Biol. Pharm. Bull. 2010, 33:983-987.
5. Bernatova I., Pechanova O., Babal P., Kysela S., Stvrtina S., Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am. J. Physiol. 2002, 282:942-948.
6. Bernatova I., Pechanova O., Simko F. Effect of captopril in l-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp. Physiol. 1999, 84(6):1095-1105.
7. Bernatova I., Pechanova O., Simko F. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiol. Res. 1996, 45:311-316.
8. Burtis C.A., Ashwood E.R. Tietz Text Book of Clinical Chemistry 1994, 1354-1370. WB Saunders Company, Philadelphia, USA. 2nd ed.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 62:156-159.
10. Curin Y., Andriantsitohaina R. Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol. Rep. 2005, 57:97-107.
11. de Gasparo M., Hess P., Nuesslein-Hildesheim B., Bruneval P., Clozel J.P. Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction. J. Renin Angiotensin Aldosterone Syst. 2000, 1:151-158.
12. De Gennaro Colonna V., Rossoni G., Rigamonti A., Bonomo S., Manfredi B., Berti F., Muller E. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in l-NAME-treated rats. Eur. J. Pharmacol. 2002, 450:61-66.
13. Delaquis P., Stanich K., Toivonen P. Effect of pH on the inhibition of Listeria spp. by vanillin and vanillic acid. J. Food Prot. 2005, 68:1472-1476.
14. Duke J.A. Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants 1992, CRC Press, Boca Raton.
15. Gottlieb A.L., Langille B.L., Wong M.K.K., Kim D.W. Biology of disease: structure and function of the endothelial cytoskeleton. Lab Invest. 1991, 65:123-127.
16. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate and nitrite in biological fluids. Anal. Biochem. 1982, 126:131-138.
17. Guedes D.N., Silva D.F., Barbosa-Filho J.M., Medeiros I.A.D. Endothelium dependent hypotensive and vasorelaxant effects of the essential oil from aerial parts of Mentha×villosa in rats. Phytomedicine 2004, 11:490-497.
18. Hirata Y., Nagata D., Suzuki E., Nishimatsu H., Suzuki J., Nagai R. Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int. Heart J. 2010, 51:1-6.
19. Jalili T., Carlstrom J., Kim S., Freeman D., Jin H., Wu T.C., Litwin S.E., David Symons J. Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J. Cardiol. Pharmacol. 2006, 47:531-541.
20. Kanematsu Y., Tsuchiya K., Ohnishi H., Motobayashi Y., Izawa Y., Ishihara M., Ishizawa K., Abe S., Kawazoe K., Tamaki T. Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nω-nitro-l-arginine methyl ester-treated rats. Hypertens. Res. 2006, 29:369-374.
21. Kang D.G., Kim J.W., Lee J. Effects of nitric oxide synthesis inhibition on the Na, K-ATPase activity in the kidney. Pharmacol. Res. 2000, 41:123-127.
22. Kang D.G., Sohn E.J., Lee Y.M., Lee A.S., Han J.H., Kim T.Y., Lee H.S. Effects of Bulbusfritillaria water extract on blood pressure and renal functions in the l-NAME-induced hypertensive rats. J. Ethnopharmacol. 2004, 91:51-56.
23. Kassan M., Montero M.J., Sevilla M.A. Chronic treatment with pravastatin prevents early cardiovascular changes in spontaneously hypertensive rats. Br. J. Pharmacol. 2009, 158:541-547.
24. Katsumi H., Nishikawa M., Hashida H. Development of nitric oxide donors for the treatment of cardiovascular diseases. Cardiovasc. Hematol. Agents Med. Chem. 2007, 5:204-208.
25. Khokhar S., Apenten R.K.O. Iron binding characteristics of phenolic compounds: some tentative structure-activity relations. Food Chem. 2003, 81:133-140.
26. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Nonalcoholic steatohepatitis clinical research network, design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatalogy 2005, 41.
27. Kumar S., Prahalathan P., Raja B. Antihypertensive and antioxidant potential of vanillic acid, a phenolic compound in l-NAME-induced hypertensive rats: a dose-dependence study. Redox Rep. 2011, 16:208-215.
28. Leiba A., Vald A., Peleg E., Shamiss A., Grossman E. Does dietary recall adequately asses sodium, potassium and calcium intake in hypertensive patients. Nutrition 2005, 21:462-466.
29. Liu P., Xu B., Forman L.J., Carsia R., Hock C.E. l-NAME enhances microcirculatory congestion and cardiomyocyte apoptosis during myocardial ischemia-reperfusion in rats. Shock 2002, 17:185-192.
30. Machha A., Schechter A.N. Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits. Eur. J. Nutr. 2012, 50:293-303.
31. Mattila P., Kumpulainen J. Determination of free and total phenolic acids in plant-derived foods by high performance liquid chromatography with diode-array detection. J. Agric. Food Chem. 2002, 50:3660-3667.
32. Mattson D.L., Kunert M.P., Roman R.J., Jacob H.J., Cowley A.W. Substitution of chromosome 1 ameliorates l-NAME hypertension and renal disease in the fawn-hooded hypertensive rat. Am. J. Physiol. Renal Physiol. 2005, 288:1015-1022.
33. Michalska M., Gluba A., Mikhailidis D.P., Nowak P., Bielecka-Dabrowa A., Rysz J., Banach M. The role of polyphenols in cardiovascular disease. Med. Sci. Monit. 2010, 16:110-119.
34. Moncada S., Higgs E.A. The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 2006, 147:193-201.
35. Moreno H., Piovesan Nathan L., Pereira Costa S.K., Metze K., Antunes E., Zatz R., De Nucci G. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur. J. Pharmacol. 1995, 287:93-96.
36. Mori M. Electron microscopic and new microscopic studies of hepatocyte cytoskeleton: physiological and pathological relevance. J. Electron. Microsc. (Tokyo) 1994, 43:347-355.
37. Mulvany M.J., Baumbach G.L., Aalkjaer C., Heagerty A.M., Korsgaard N., Schiffrin E.L., Heistad D.D. Vascular remodeling. Hypertension 1996, 28:505-506.
38. Ogita H., Liao J. Endothelial function and oxidative stress. Endothelium 2004, 11:123-132.
39. Olzinski A.R., McCafferty T.A., Zhao S.Q., Behm D.J., Eybye M.E., Maniscalco K., Bentley R., Frazier K.S., Milliner C.M., Mirabile R.C., Coatney R.W., Willette R.N. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection. Cardiovasc. Res. 2005, 66:170-178.
40. Opie L.H., Cammerford P.J., Gerch B.J., Pfeffer M.A. Controversies in cardiology 4 Controversies in ventricular remodeling. Lancet 2006, 367:356-376.
41. Panchal S.K., Poudyal H., Iyer A., Nazer R., Alam M.A., Diwan V., Kauter K., Sernia C., Campbell F., Ward L., Gobe G., Fenning A., Brown L. High carbohydrate high fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J. Cardiovasc. Pharmacol. 2011, 57:611-624.
42. Pechanova O., Bernatova I., Babal P., Martinez M.C., Kysela S., Stvrtina S., Andriantsitohaina R. Red wine polyphenols prevent cardiovascular alterations in l-NAME-induced hypertension. J. Hypertens. 2004, 22:1551-1559.
43. Pereira L.M., Bezerra D.G., Machado D.L., Mandarim-de-Lacerda C.A. Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats. Clin. Sci. (Lond.) 2004, 106:337-343.
44. Pereira L.M., Mandarim-De-Lacerda C.A. Quantitative study of myocardial microcirculation in arterial hypertension due to progressive inhibition of NO synthesis. Arq. Bras. Cardiol. 1999, 73:407-418.
45. Perez-Vizcaino F., Duarte J., Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic. Res. 2006, 40:1054-1065.
46. Portaluppi F., Boari B., Manfredini R. Oxidative stress in essential hypertension. Curr. Pharmacol. Dis. 2004, 10:1695-1698.
47. Prado C.M., Rossi M.A. Circumferential wall tension due to hypertension plays a pivotal role in aorta remodeling. Int. J. Exp. Pathol. 2006, 87:425-436.
48. Rai R.P., Maurya M.S. Synthesis and evaluation of antibacterial activity of vanillin derivatives. J. Sci. Technol. 1996, 4:275-276.
49. Raja B., DeepaMol S. The protective role of vanillic acid against acetaminophen induced hepatotoxicity in rats. J. Pharm. Res. 2010, 3:1480-1484.
50. Roberts C.K., Barnard R.J., Jasman A., Balon T.W. Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am. J. Physiol. 1999, 277:390-394.
51. Rossi M.A., Colombini-Netto M. Chronic inhibition of NO synthesis per se promotes structural intimal remodeling of the rat aorta. J. Hypertens. 2001, 19:1567-1579.
52. Sanada S., Node K., Minamino T., Takashima S., Ogai A., Asanuma H., Ogita H., Liao Y., Asakura M., Kim J., Hari M., Kitakaze M. Long acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats. Hypertension 2003, 41:963-967.
53. Saravanakumar M., Raja B. Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in l-NAME induced hypertensive rats. Eur. J. Pharmacol. 2011, 671:87-94.
54. Sinha S.N., Karppanen H. Minerals and blood pressure. Ann. Med. 1991, 23:299-305.
55. Smith R.S., Agata J., Xia C.F., Chao L., Chao J. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci. 2005, 76:2457-2471.
56. Souza H.C.D., Ballejo G., Salgado M.C.O., Dias da Silva V.J., Salgado H.C. Cardiac sympathetic over activity and decreased baroreflex sensitivity in l-NAME hypertensive rats. Am. J. Physiol. 2001, 280:844-850.
57. Stanely Mainzen Prince P., Dhanasekar K., Rajakumar S. Protective effects of vanillic acid on electrocardiogram, lipid peroxidation, antioxidants, proinflammatory markers and histopathology in isoproterenol induced cardiotoxic rats. Eur. J. Pharmacol. 2011, 668:233-240.
58. Stanely Mainzen Prince P., Dhanasekar K., Rajakumar S. Preventive effects of vanillic acid on lipids, Bax Bcl-2 and myocardial infarct size on isoproterenol-induced myocardial infarcted rats: a biochemical and in vitro study. Cardiovasc. Toxicol. 2011, 11:58-66.
59. Tibirica E., Almeida A., Caillleaux S., Pimenta D., Kaplan M.A., Lessa M.A., Figueiredo M.R. Pharmacological mechanisms involved in the vasodilator effects of extracts from Echinodorus grandiflorus. J. Ethnopharmacol. 2007, 111:50-55.
60. Torok J. Participation of nitric oxide in different models of experimental hypertension. Physiol. Res. 2008, 57:813-825.
61. Touyz R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 2004, 44:248-252.
62. Tsuda H., Uehara N., Iwahori Y., Asamoto M., Ligo M., Nagao M. Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimi-dazo[4,5]quinoline in the rat. Jpn. J. Cancer Res. 1994, 85:1214-1219.
63. Tsukahara H., Hiraoka M., Kobata R., Hata I., Ohshima Y., Jiang M.Z., Noiri E., Mayumi M. Increased oxidative stress in rats with chronic nitric oxide depletion: measurement of urinary 8-hydroxy-2'-deoxyguanosine excretion. Redox Rep. 2000, 5:23-28.
64. Varma R.S., Shukla A., Chatterjee R.K. Evaluation of vanillic acid analogues as a new class of antifilarial agents. Indian J. Exp. Biol. 1993, 31:819-821.
65. Yang H.Y., Yang S.C., Chen S.T., Chen J.R. Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with l-NAME-induced hypertension. J. Nutr. Biochem. 2008, 19:833-839.
66. Zhou K., Yin J.J., Yu L. ESR determination of the reaction between selected phenolic acids and free radicals or transition metals. Food chem. 2006, 95:446-457.